Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?

ABSTRACT:

Objective

To determine if there are variations in the receipt of treatment based on race and disease severity. Treatment variations in men with prostate cancer (PCa) among the various racial groups in the United States exist, which may be a source of potential disparity in outcome.

Methods

Utilizing Surveillance, Epidemiology and End Results 17, we identified 327,636 men diagnosed with PCa from 2004 to 2011. Logistic regression analysis was performed to determine the association of receiving definitive treatment and race in the context of disease severity.

Results

African American (AA) and Hispanic men were less likely to receive treatment compared to White men (odds ratio [OR] 0.73, 95% confidence interval [CI] 0.71, 0.75, and OR 0.95, 95% CI 0.92, 0.98, respectively

SUBMITTER: Moses KA 

PROVIDER: S-EPMC5191943 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature